ISRCTN57684399
Completed
未知
A randomised exploratory trial of a pharmacist-led home based clinical medication review in people after stroke
HS Lothian (UK)0 sites60 target enrollmentMay 12, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Topic: Stroke Research Network
- Sponsor
- HS Lothian (UK)
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with stroke due for discharge home from acute, rehabilitation or out\-patient neurovascular clinic settings
- •2\. Male and female, aged 53\-92 years
Exclusion Criteria
- •1\. Discharge to long\-term care
- •2\. Terminal serious illness
- •3\. Severe confusion such that the patient does not have capacity to understand or give informed consent
- •4\. Unable to nominate a community pharmacy
- •5\. Severe dysphasia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Can a pharmacist-led education and support intervention assist patients to reduce their glucocorticoid (steroid) dose and improve outcomes for patients with rheumatic diseases?Rheumatoid arthritisPolymalgia RheumaticaGiant Cell ArteritisSystemic Lupus ErythematosusInflammatory MyositisInflammatory and Immune System - Rheumatoid arthritisInflammatory and Immune System - Autoimmune diseasesInflammatory and Immune System - Connective tissue diseasesPublic Health - Health service researchACTRN12624000817549Central Adelaide Local Health Network100
Recruiting
Not Applicable
A randomized exploratory clinical trial to evaluate the effectiveness of the chimsband therapy for pain after shoulder arthroscopic surgeryKCT0002355Korea Institute of Oriental Medicine30
Completed
Not Applicable
PCT of Pharmacopuncture Therapy for Cervical Disc Herniation: A Pilot StudyKCT0007057Jaseng Hospital of Korean Medicine84
Recruiting
Not Applicable
Pragmatic randomized controlled trial of pharmacopuncture therapy for chronic low back paiKCT0006088Jaseng Medical Foundation100
Active, not recruiting
Not Applicable
study of effective pharmacological cardioversion of paroxysmal atrial fibrillation with flecainide vs vernakalantAtrial fibrillation paroxysmalMedDRA version: 17.1Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-003641-95-ESicasio Pérez Castellano